FDA greenlights first drug-eluting stent in more than three years

RSS

HealthImaging.com, February 19, 2008

The Food and Drug Administration has approved Medtronic's Endeavor zotarolimus-eluting coronary stent system to be used in the treatment of coronary artery disease. It is the first new drug-eluting stent to be approved by the FDA since 2004.

Full Story

FDA doesn’t enforce standards for sterile healthcare products manufacturer

It's impossible for the public to know when regulators first discovered Bacillus cereus at H&P Industry's plant because the FDA heavily redacted details from a decade's worth of inspection reports provided...

Web Exclusive: FDA Approves 3-D Mammography Machine

Radiologists find that images created from the three-dimensional scans are better at detecting cancers and results of clinical trials showed a 15% increase in the amount of cancers caught, and a 30% decrease...

Web Exclusive: 80 Percent of Recalled Medical Devices Got Little FDA Scrutiny

Of 113 medical devices recalled by the FDA between 2005 and 2009 because they were dangerous, 81% had been cleared under a lenient approval process revealing "critical flaws" in the federal...

Book: Complete Guide to Lab Safety, 3rd Ed.

The third edition of this popular resource makes training and compliance easier by consolidating regulations from all relevant agencies (OSHA, Joint Commission, CAP, CLSI, DOT, state health...

go to complete list